about
Risk of erectile dysfunction induced by arsenic exposure through well water consumption in TaiwanThe benefits and risks of testosterone replacement therapy: a reviewTestosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.Sexual dysfunctions among people living with AIDS in BrazilFunctional testosterone: biochemical assessment of hypogonadism in men--report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists.Androgens and male aging: Current evidence of safety and efficacy.Impact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severity.Recent topics related to testosterone deficiency syndrome in Japan.The Relationship between Testosterone Deficiency and Men's HealthISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafilTestosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment.Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy.Testosterone replacement therapy: should it be performed in erectile dysfunction?The use of hormonal therapy in "andropause": the pro side.Dr. Morales' rebuttalAnalysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men.ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms.Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?Treatment with human chorionic gonadotropin for PADAM: a preliminary report.Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research.Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study.Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan.Role of Tissue-Specific Stem and Progenitor Cells in the Regeneration of the Pancreas and Testicular Tissue in Diabetic Disorders.Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function.No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9–12 February 2006, Salzburg, Austria
P2860
Q24657523-B8A5D5A9-0576-402C-8B70-23AD7BA34058Q24658011-2AA1681B-F1D4-4010-B48C-78F1F6898D02Q33276072-10D3DFB8-939D-4FB4-B708-2FA5BACB9B71Q33901146-9D7B29F7-E0EA-4F12-AB96-B8632D6AC1DFQ37011536-4FD5E59B-4D60-49AB-AB0A-77AD9C601BCCQ37084126-3E2B5568-9D16-410B-ABE1-9DDC7AC60503Q37084395-EA18179A-D03B-492B-BD78-664AC7847F88Q37085390-B02B0E5E-43E6-46F0-9157-8F89B96CB7EFQ37165023-90A6C52C-D309-49C2-9208-EBFFD4A28F6CQ37299250-1DF3BBE1-CB75-4223-A798-050ACC700951Q37310024-50B514A6-4C9E-4219-B71D-BA8CB110F9A1Q37423701-765FAC56-2399-4D29-80CD-641D2B268AD8Q37531111-30221A27-812D-4BBE-89F6-0C70637E31B3Q37886153-F2281031-BA2A-4B6E-BCA2-073A8D4CF573Q38172216-C31B8D4B-351D-460B-9A01-6A9814759CE0Q39020143-7DB6F4E4-A6F4-4C6C-AC93-016786AFCEE8Q39020243-40FE14FE-B931-45D7-B93B-4A8D7B8E5DBAQ41352741-21A1A8F6-A8B9-40E5-B508-C22A4EAC273DQ46397195-7654E71D-BBB5-4E37-9A15-720C0D79989EQ46526822-0D952FC5-C661-4DCD-AF9B-782C7A520E06Q46596427-5902A5BD-01DA-4612-A71D-15E06D0D68A2Q46877608-285C0440-6E98-4DD6-8602-4FFEA54309AAQ46886078-B11BBB4C-4EBE-49BE-85BE-921301E458F8Q46984861-14E7A40D-7984-4A56-A567-904749900761Q47368269-E3AF86C2-030A-4AC0-BE65-7562955863C4Q48501272-D78670CA-FA1D-4DB2-9703-9723A29A0C7EQ51308861-8FB6FBBC-AAF9-4B54-AB26-A89BF10B979AQ51469595-A9CBBA1C-8F94-4337-B2D2-029D340EBA6DQ51749233-3C1A4A39-3AA0-4FB3-9EC8-888DB5A96399Q58176907-D14465DA-45C2-485C-A98E-EA765120BDF1
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Endocrine aspects of sexual dysfunction in men.
@ast
Endocrine aspects of sexual dysfunction in men.
@en
type
label
Endocrine aspects of sexual dysfunction in men.
@ast
Endocrine aspects of sexual dysfunction in men.
@en
prefLabel
Endocrine aspects of sexual dysfunction in men.
@ast
Endocrine aspects of sexual dysfunction in men.
@en
P2093
P1476
Endocrine aspects of sexual dysfunction in men.
@en
P2093
Alvaro Morales
Andre T Guay
Hui Meng Tan
Jacques Buvat
Jean-Marc Kaufman
Louis J Gooren
Luiz O Torres
P356
10.1111/J.1743-6109.2004.10111.X
P577
2004-07-01T00:00:00Z